Literature DB >> 1435687

Influenza surveillance--United States, 1991-92.

J H Kent, L E Chapman, L M Schmeltz, H L Regnery, N J Cox, L B Schonberger.   

Abstract

During the 1991-92 influenza season, sustained regional influenza activity began to be reported by state and territorial epidemiologists in the United States in mid-October 1991. Sustained reporting of widespread influenza activity began in early November 1991, 5-10 weeks earlier than in any of the previous nine influenza seasons. Influenza caused substantial morbidity among school-age children and excess mortality among the elderly. Regional outbreaks of influenza ended 2-6 weeks earlier than in the previous nine influenza seasons, based on the last sustained state and territorial epidemiologists' reports. Nationally, > 99% of isolates were influenza A. Influenza A(H3N2) predominated in all regions of the country, but isolation of influenza A(H1N1) increased proportionally as the season progressed. Isolation of influenza B (< 1% of total isolates) clustered after February. The majority of isolates characterized were antigenically similar to components in the 1991-92 influenza vaccine. However, an influenza A(H1N1) strain that had undergone antigenic drift was detected in many regions of the country; this strain will be included in the 1992-93 influenza vaccine.

Entities:  

Mesh:

Year:  1992        PMID: 1435687

Source DB:  PubMed          Journal:  MMWR CDC Surveill Summ


  2 in total

1.  Glycyrrhizin, an active component of licorice roots, reduces morbidity and mortality of mice infected with lethal doses of influenza virus.

Authors:  T Utsunomiya; M Kobayashi; R B Pollard; F Suzuki
Journal:  Antimicrob Agents Chemother       Date:  1997-03       Impact factor: 5.191

2.  Safety and efficacy of long-term use of rimantadine for prophylaxis of type A influenza in nursing homes.

Authors:  A S Monto; S E Ohmit; K Hornbuckle; C L Pearce
Journal:  Antimicrob Agents Chemother       Date:  1995-10       Impact factor: 5.191

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.